Close menu




December 27th, 2021 | 09:03 CET

Infineon, BrainChip, Nvidia - The chip market remains hot

  • Technology
Photo credits: pixabay.com

First and foremost, the automotive sector suffered from a lack of chips in 2021. Blaming everything on Corona alone is too short-sighted. The pandemic is certainly a factor, but the rapid economic recovery caught companies off guard. Added to this was digitization, partly also pandemic-related, which boosted demand for semiconductors more than the already high structural semiconductor demand. A few weather-related production stoppages and disrupted supply chains later, the situation was as it currently stands. Intel does not expect the situation to slowly calm down until 2023. Reason enough to take a look at three chip manufacturers.

time to read: 4 minutes | Author: Armin Schulz
ISIN: INFINEON TECH.AG NA O.N. | DE0006231004 , BRAINCHIP HOLDINGS LTD | AU000000BRN8 , NVIDIA CORP. DL-_001 | US67066G1040

Table of contents:


    Infineon - Competitor helps with good figures

    Infineon almost has to be considered an exotic player in the semiconductor industry. Most chips are manufactured in Asia or the USA. Infineon, on the other hand, operates from Europe. Things went very well for the Company in 2021, even though the share only managed to break out to the upside at the end of October. Even in times of crisis, the Company emphasized that prices for customers would only rise moderately, if at all. In contrast, its competitors were asking customers to pay a fair amount. Infineon's management justified this approach by saying that it always wanted to work with customers long-term.

    The fiscal year ended on September 30, and the Company reported a 29% increase in sales. The margin is 18.7%. CEO Ploss believes the Company is also well prepared for the coming year: "Given the continued high demand for semiconductors for the energy-efficient and connected world, we expect a strong fiscal year 2022."

    The semiconductor market is doing well, as most recently shown by Micron, which presented figures on December 21, exceeding analysts' expectations. This news also boosted the Infineon share, which had recently consolidated after the substantial rise. Thus, the share was able to start the rebound at the support level of EUR 38.50. On December 23, the Company announced that Black Rock had further increased its position. UBS recently raised the price target from EUR 45 to EUR 49 and continues to rate the stock as a "buy".

    BrainChip - Milestone reached

    The Australian Company BrainChip has developed a special kind of chip. The Akida chip is used as edge AI, i.e. artificial intelligence on the chip itself, without cloud and internet connection. The chip does not need a CPU to do its calculations but works autonomously and responds to impulses and events. As a result, Akida requires much less power. This approach makes it attractive for IoT devices, autonomous driving, security technology, and more. In addition, this technology is significantly more secure and meets the more stringent data protection requirements when used.

    Sales of development kits for X86 and ARM systems started at the end of October. On November 21, the Company signed a cooperation agreement with MegaChips. MegaChips will integrate the Akida technology into their products, which should benefit both companies. In addition to the license fees that BrainChip collects, additional revenues could beckon through application-specific developments and projects of all kinds in cooperation between the two parties. For BrainChip, the deal means about USD 2 million in revenue in 2022 and direct access to MegaChips' customers.

    MegaChips plans to market the Akida chips to the automotive industry and companies with robot production. The artificial intelligence sector is expected to grow strongly in the coming years. Since October, the share has risen from AUD 0.365 to AUD 0.75. Since then, the stock has been consolidating and is currently trading at AUD 0.66. Only a closing price below AUD 0.595 would break the intact upward trend. The analysts at Pitt Street Research see AUD 1.50 as a price target. Therefore, the share has much more potential than the current share price.

    Nvidia - Omniverse on the rise

    Originally, Nvidia's main business was the production of graphics cards, but over the last few years, the artificial intelligence (AI) business in the data center is growing faster and faster and will become the primary revenue driver in the coming years. Many experts consider the Company to be a leader in AI, so it is not surprising that Nvidia continues to expand in this area. At the beginning of November, it presented its visions at the BEYOND event, including autonomous driving and AI-controlled assistants for corporate customers.

    An analysis by Forrester Research suggests that AI is changing the world. 74% of the companies surveyed said that the introduction of AI has had a positive impact. Nvidia itself sees the Metaverse, referred to by the Company as the Omniverse, as an important upcoming market. It expects revenues to rise sharply in the coming years. By 2025, it should already be USD 400 billion, according to crypto firm Grayscale. The US analyst firm Needham expects 100 million digital bots in the virtual world.

    Nvidia is therefore involved in many future topics. We should also mention cloud gaming, which also promises decent growth, in addition to the already mentioned areas. The shortage of GPUs will remain for the foreseeable future, even though China has banned crypto mining. The stock has recently suffered a minor setback. It went down from USD 346.47 to USD 271.45. A double bottom was formed there, and since then, the stock has been rising again to currently USD 296.40.


    Conclusion

    The chip shortage remains for the time being, and the topic of AI is becoming increasingly important. Infineon will have no problems selling its produced chips in the coming year. BrainChip has found a strong partner to produce and distribute its AI chips. Nvidia is and remains the top dog in AI and is excellently positioned in many future-oriented areas.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Armin Schulz

    Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.

    About the author



    Related comments:

    Commented by Stefan Feulner on January 26th, 2026 | 07:25 CET

    NEO Battery Materials positions itself for the battery revolution

    • Batteries
    • BatteryMetals
    • Technology
    • Investments

    Artificial intelligence, autonomous systems, drones, and robotics are causing global energy demand to skyrocket. But this is precisely where the weak point of digitalization becomes apparent. Conventional lithium-ion batteries are reaching their physical limits in terms of charging time, energy density, and cost. NEO Battery plans to break through this bottleneck. With innovative silicon anode technology, the Company promises significantly higher capacities, ultra-fast charging, and massive cost advantages. Initial partnerships with major customers, concrete supply agreements, and the expansion of production capacities are fueling imagination and increasingly bringing the battery specialist into the focus of investors.

    Read

    Commented by Fabian Lorenz on January 26th, 2026 | 01:35 CET

    BASF under PRESSURE! BUY RECOMMENDATIONS for BioNTech and WashTec shares!

    • carwash
    • Technology
    • chemicals
    • Biotechnology

    Market leadership, increased efficiency, dividends, and share buybacks - all good reasons to buy WashTec shares. Analysts at M.M. Warburg share this assessment. Their earnings estimates for the coming years may even be too conservative. Unfortunately, nothing about BASF is conservative; rather, it is disappointing. The chemical company has once again failed to meet analysts' forecasts. Its strong free cash flow is based on lower investments, which is also not a good sign. How are analysts reacting? BioNTech is facing a groundbreaking year. Analysts see potential for share price growth. News from the bulging product pipeline is likely to have a significant impact on the share price.

    Read

    Commented by Nico Popp on January 23rd, 2026 | 07:15 CET

    Revolution in agricultural chemistry: How MustGrow Biologics is benefiting from the plight of Bayer and Corteva

    • Agriculture
    • Technology
    • Agriscience
    • Biotechnology

    Global agriculture is at a historic turning point, driven less by a belief in technological progress than by regulatory necessity. For decades, global food security has been based on synthetic pesticides and fertilizers, but that era is rapidly coming to an end. Authorities from Brussels to California are tightening the screws and banning established active ingredients one after the other because their ecological collateral damage is no longer tolerated. For the agricultural giants, this poses an existential threat: their full warehouses are in danger of becoming worthless if they do not find effective biological alternatives quickly enough. In the current extremely hectic environment in industry, which is characterized by billion-dollar acquisitions and strategic alliances, new power structures are emerging. While Corteva Agriscience is aggressively buying market share with its chequebook and Bayer is pushing ahead with its portfolio restructuring, the Canadian company MustGrow Biologics has carved out a position that is considered the "sweet spot" in the industry. The Company is the technology partner whose active ingredients have already been validated and licensed by the market leaders.

    Read